Rocaglamide derivatives are immunosuppressive phytochemicals that target NF-AT activity in T cells

Aglaia (family Meliaceae) plants are used in traditional medicine (e.g., in Vietnam) for the treatment of inflammatory skin diseases and allergic inflammatory disorders such as asthma. Inflammatory diseases arise from inappropriate activation of the immune system, leading to abnormal expression of g...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Proksch, Peter (VerfasserIn) , Spring, Herbert (VerfasserIn) , Krammer, Peter H. (VerfasserIn) , Li-Weber, Min (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: June 1, 2005
In: The journal of immunology
Year: 2005, Jahrgang: 174, Heft: 11, Pages: 7075-7084
ISSN:1550-6606
DOI:10.4049/jimmunol.174.11.7075
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.4049/jimmunol.174.11.7075
Verlag, lizenzpflichtig, Volltext: https://www.jimmunol.org/content/174/11/7075
Volltext
Verfasserangaben:Peter Proksch, Marco Giaisi, Monika K. Treiber, Katalin Palfi, Anette Merling, Herbert Spring, Peter H. Krammer, Min Li-Weber

MARC

LEADER 00000caa a2200000 c 4500
001 1750242710
003 DE-627
005 20220819125403.0
007 cr uuu---uuuuu
008 210303s2005 xx |||||o 00| ||eng c
024 7 |a 10.4049/jimmunol.174.11.7075  |2 doi 
035 |a (DE-627)1750242710 
035 |a (DE-599)KXP1750242710 
035 |a (OCoLC)1341396811 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Proksch, Peter  |d 1953-  |e VerfasserIn  |0 (DE-588)172321964  |0 (DE-627)697229777  |0 (DE-576)133188299  |4 aut 
245 1 0 |a Rocaglamide derivatives are immunosuppressive phytochemicals that target NF-AT activity in T cells  |c Peter Proksch, Marco Giaisi, Monika K. Treiber, Katalin Palfi, Anette Merling, Herbert Spring, Peter H. Krammer, Min Li-Weber 
264 1 |c June 1, 2005 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Published online May 19, 2005 
500 |a Gesehen am 03.03.2021 
520 |a Aglaia (family Meliaceae) plants are used in traditional medicine (e.g., in Vietnam) for the treatment of inflammatory skin diseases and allergic inflammatory disorders such as asthma. Inflammatory diseases arise from inappropriate activation of the immune system, leading to abnormal expression of genes encoding inflammatory cytokines and tissue-destructive enzymes. The active compounds isolated from these plants are derivatives of rocaglamide. In this study we show that rocaglamides are potent immunosuppressive phytochemicals that suppress IFN-γ, TNF-α, IL-2, and IL-4 production in peripheral blood T cells at nanomolar concentrations. We demonstrate that rocaglamides inhibit cytokine gene expression at the transcriptional level. At the doses that inhibit cytokine production, they selectively block NF-AT activity without impairing NF-κB and AP-1. We also show that inhibition of NF-AT activation by rocaglamide is mediated by strong activation of JNK and p38 kinases. Our study suggests that rocaglamide derivatives may serve as a new source of NF-AT-specific inhibitors for the treatment of certain inflammatory diseases. 
700 1 |a Spring, Herbert  |e VerfasserIn  |0 (DE-588)1226967248  |0 (DE-627)1748078453  |4 aut 
700 1 |a Krammer, Peter H.  |d 1946-  |e VerfasserIn  |0 (DE-588)121766373  |0 (DE-627)081520255  |0 (DE-576)292873417  |4 aut 
700 1 |a Li-Weber, Min  |e VerfasserIn  |0 (DE-588)1157205399  |0 (DE-627)1021010324  |0 (DE-576)502732695  |4 aut 
773 0 8 |i Enthalten in  |t The journal of immunology  |d Rockville, Md. : American Association of Immunologists, 1916  |g 174(2005), 11, Seite 7075-7084  |h Online-Ressource  |w (DE-627)269535217  |w (DE-600)1475085-5  |w (DE-576)079963838  |x 1550-6606  |7 nnas  |a Rocaglamide derivatives are immunosuppressive phytochemicals that target NF-AT activity in T cells 
773 1 8 |g volume:174  |g year:2005  |g number:11  |g pages:7075-7084  |g extent:10  |a Rocaglamide derivatives are immunosuppressive phytochemicals that target NF-AT activity in T cells 
856 4 0 |u https://doi.org/10.4049/jimmunol.174.11.7075  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.jimmunol.org/content/174/11/7075  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210303 
993 |a Article 
994 |a 2005 
998 |g 1157205399  |a Li-Weber, Min  |m 1157205399:Li-Weber, Min  |d 50000  |e 50000PL1157205399  |k 0/50000/  |p 8  |y j 
998 |g 121766373  |a Krammer, Peter H.  |m 121766373:Krammer, Peter H.  |d 50000  |e 50000PK121766373  |k 0/50000/  |p 7 
998 |g 1226967248  |a Spring, Herbert  |m 1226967248:Spring, Herbert  |d 50000  |e 50000PS1226967248  |k 0/50000/  |p 6 
999 |a KXP-PPN1750242710  |e 3880807922 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"recId":"1750242710","note":["Published online May 19, 2005","Gesehen am 03.03.2021"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title":"Rocaglamide derivatives are immunosuppressive phytochemicals that target NF-AT activity in T cells","title_sort":"Rocaglamide derivatives are immunosuppressive phytochemicals that target NF-AT activity in T cells"}],"person":[{"roleDisplay":"VerfasserIn","display":"Proksch, Peter","role":"aut","family":"Proksch","given":"Peter"},{"display":"Spring, Herbert","roleDisplay":"VerfasserIn","role":"aut","family":"Spring","given":"Herbert"},{"given":"Peter H.","family":"Krammer","role":"aut","roleDisplay":"VerfasserIn","display":"Krammer, Peter H."},{"given":"Min","family":"Li-Weber","role":"aut","display":"Li-Weber, Min","roleDisplay":"VerfasserIn"}],"relHost":[{"title":[{"title_sort":"journal of immunology","title":"The journal of immunology"}],"pubHistory":["1.1916 -"],"part":{"text":"174(2005), 11, Seite 7075-7084","volume":"174","extent":"10","year":"2005","pages":"7075-7084","issue":"11"},"note":["Gesehen am 18.08.2025"],"disp":"Rocaglamide derivatives are immunosuppressive phytochemicals that target NF-AT activity in T cellsThe journal of immunology","type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"corporate":[{"role":"isb","display":"American Association of Immunologists","roleDisplay":"Herausgebendes Organ"}],"recId":"269535217","origin":[{"dateIssuedDisp":"2025-","dateIssuedKey":"2025","publisher":"Oxford University Press ; Soc. ; American Association of Immunologists","publisherPlace":"Oxford ; Bethesda, Md. ; Rockville, Md."}],"id":{"eki":["269535217"],"zdb":["1475085-5"],"issn":["1550-6606"]},"name":{"displayForm":["American Association of Immunologists"]},"physDesc":[{"extent":"Online-Ressource"}]}],"physDesc":[{"extent":"10 S."}],"id":{"doi":["10.4049/jimmunol.174.11.7075"],"eki":["1750242710"]},"origin":[{"dateIssuedDisp":"June 1, 2005","dateIssuedKey":"2005"}],"name":{"displayForm":["Peter Proksch, Marco Giaisi, Monika K. Treiber, Katalin Palfi, Anette Merling, Herbert Spring, Peter H. Krammer, Min Li-Weber"]}} 
SRT |a PROKSCHPETROCAGLAMID1200